Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,424.85 162.29 1.00%
S&P 500 1,862.31 19.33 1.05%
NASDAQ 4,086.22 52.06 1.29%
Ticker Volume Price Price Delta
STOXX 50 3,139.26 47.74 1.54%
FTSE 100 6,584.17 42.56 0.65%
DAX 9,317.82 144.11 1.57%
Ticker Volume Price Price Delta
NIKKEI 14,417.68 420.87 3.01%
TOPIX 1,166.55 30.46 2.68%
HANG SENG 22,696.01 24.75 0.11%

Technical Study: Johnson & Johnson, Mylan Inc., Brookdale Senior Living Inc., and Array BioPharma Inc.



Technical Study: Johnson & Johnson, Mylan Inc., Brookdale Senior Living Inc.,
                           and Array BioPharma Inc.

PR Newswire

LONDON, November 19, 2013

LONDON, November 19, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

The U.S. equity market ended on a mixed note on Monday, November 18, 2013. The
S&P 500 ended the day at 1,791.53, down 0.37%; the Dow Jones Industrial
Average closed at 15,976.02, up 0.09%; and the NASDAQ Composite finished at
3,949.07, down 0.93%. Shares in the healthcare sector ended on lower note,
even as the broader market traded between gains and losses. The major movers
in the industry included Johnson & Johnson (NYSE:JNJ), Mylan Inc.
(NASDAQ:MYL), Brookdale Senior Living Inc. (NYSE:BKD), and Array BioPharma
Inc. (NASDAQ:ARRY). AAAResearchReports.com free coverage on JNJ, MYL, BKD, and
ARRY is available upon registration at:

http://www.aaaresearchreports.com/register/  

On Monday, Johnson & Johnson's stock finished the day at $94.30, which is
0.10% lower than the previous day's closing price of $94.39. The company's
shares fluctuated between $94.01 and $94.60 during the trading session. A
total of 8.48 million shares were traded, which is above the daily average
volume of 7.73 million. Despite Monday's losses, the company's shares have
gained 2.91% in the last one month and 5.52% in the previous three months,
compared to a gain of 2.70% and 8.20% in the S&P 500 during the respective
periods. Additionally, Johnson & Johnson's stock is trading near its 52-week
high of $94.64 and above its 50-day and 200-day moving averages of $90.27 and
$86.06, respectively. Download free technical research on JNJ by signing up
at:

http://www.AAAResearchReports.com/JNJ111913.pdf

Mylan Inc.'s stock fluctuated between $41.51 and $42.44 before ending Monday's
session 1.31% lower at $41.81. A total of 4.58 million shares were traded,
which is above the daily average volume of 4.30 million.  Despite Monday's
pullback, the company's shares have gained 8.45% in the last one month and
15.52% in the previous three months, outperforming the S&P 500, which has
gained 2.70% and 8.20% during the respective periods. Further, Mylan Inc.'s
stock is trading near its 52-week high of $42.45 and above its 50-day and
200-day moving averages of $39.14 and $33.17, respectively. Register now and
get access to free analysis on MYL at:

http://www.AAAResearchReports.com/MYL111913.pdf  

On Monday, shares in Brookdale Senior Living Inc. edged lower to end the day
at $29.40, down 1.61% from the previous day's closing price of $29.88. The
company's shares vacillated between $29.29 and $29.96 during the trading
session. A total of 0.68 million shares were traded, which is below the daily
average volume of 1.21 million. Despite Monday's losses, the company's shares
have gained 4.85% in the last one month and 6.68% in the previous three
months, compared to a gain of 2.70% and 8.20% in the S&P 500 during the
respective periods. Moreover, Brookdale Senior Living Inc.'s stock is trading
above its 50-day and 200-day moving averages of $27.10 and $27.58,
respectively. Sign up and read our complimentary report on BKD at:

http://www.AAAResearchReports.com/BKD111913.pdf

Shares in Array BioPharma Inc. plummeted on Monday, even as the broader market
ended on a mixed note. The company's shares traded between $5.50 and $5.75
before ending the day 2.64% lower at $5.53. A total of 0.86 million shares
were traded, which is below the daily average volume of 1.81 million. Despite
Monday's decline, the company's shares have gained 1.75% in the last one
month, compared to a gain of 2.70% in the S&P 500 during the same period.
Furthermore, Array BioPharma Inc.'s stock is trading above its 200-day moving
average of $5.37. The free report on ARRY can be downloaded by signing up now
at:

http://www.AAAResearchReports.com/ARRY111913.pdf

EDITOR NOTES:

 1. This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
 2. Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
    only human and are prone to making mistakes. If you notice any errors or
    omissions, please notify us below.
 3. This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
 4. If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
 5. For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
 6. Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

http://www.AAAResearchReports.com/

SOURCE AAA Research Reports

Contact: Contact Name: Peter F. Jones - Phone #: +1(646)396-9126, Email ID:
info@aaaresearchreports.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement